MarketCap
Facebook
X
TelegramFluidigm Corporation Kurzfristige Verbindlichkeiten 2011-2026 | FLDM
Kurzfristige Verbindlichkeiten Jährlich Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 54.2 M | 32.8 M | 37.6 M | 33.5 M | 29.5 M | 30.1 M | 29.4 M | 18 M | 11.6 M | 20.2 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 54.2 M | 11.6 M | 29.7 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
1.97 M | $ 3.03 | -2.42 % | $ 98.3 K |  USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 34.75 | 2.9 % | $ 374 M |  China |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.34 | -8.84 % | $ 1.7 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 39.22 | 0.15 % | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
5.75 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
6.8 B | $ 218.15 | -0.6 % | $ 159 B | USA |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 102.45 | 0.14 % | $ 19 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 26.05 | -0.72 % | $ 788 M | USA |
 |
Guardant Health
GH
|
226 M | $ 112.47 | 1.8 % | $ 13.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
1.56 B | $ 73.19 | -1.09 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 20.35 | -2.18 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
31.7 M | $ 109.11 | -2.68 % | $ 4.3 B | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 10.14 | -1.55 % | $ 288 M | Israel |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 66.29 | -0.59 % | $ 4.59 B | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 144.63 | -3.38 % | $ 23 B | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 229.55 | -2.52 % | $ 41.6 B | USA |
 |
NeoGenomics
NEO
|
301 M | $ 11.92 | -3.87 % | $ 1.51 B | USA |
 |
Charles River Laboratories International
CRL
|
994 M | $ 209.14 | -1.23 % | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
1.1 B | $ 584.25 | -1.49 % | $ 18.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 185.48 | 1.74 % | $ 20.6 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 9.45 | -2.17 % | $ 1.23 B | USA |
 |
Personalis
PSNL
|
31.1 M | $ 9.32 | -6.47 % | $ 552 M | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
3.14 M | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 269.98 | 0.06 % | $ 22.7 B | USA |
 |
Mettler-Toledo International
MTD
|
1.17 B | $ 1 380.08 | -0.92 % | $ 29.3 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 179.68 | -3.34 % | $ 14.8 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.07 B | $ 672.01 | -0.69 % | $ 55.4 B | USA |
 |
Agilent Technologies
A
|
1.71 B | $ 132.44 | -0.6 % | $ 40.3 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.35 | -1.67 % | $ 5.4 M | USA |